Some factors affecting ouabain-induced ventricular arrhythmia in the reserpine-treated cat.
D000315:Adrenalectomy; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001831:Body Temperature / Q000187:drug effects*; D005117:Cardiac Complexes, Premature / Q000139:chemically induced*; D002415:Cats; D005260:Female; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D010042:Ouabain / Q000494:pharmacology* / Q000633:toxicity; D012110:Reserpine / Q000494:pharmacology*; D012723:Sex; D013564:Sympathetic Nervous System / Q000187:drug effects; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D006584:Hexamethonium Compounds; D010042:Ouabain; D012110:Reserpine